Best deals to access real time data! |
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
DDE w/Realtime (Monthly)
Monthly Subscription
for only
|
|
Big Cap Pro
Monthly Subscription
for only
|
|
VAT not included
|
|
After Hours Last Trade |
Last $ 4.15 ◊ 0.00 (0.00%) | |
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Aptinyx Inc | APTX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | High Price | Low Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| 0.16 | 4.01% | 4.15 | 4.22 | 4.00 | 4.02 | 3.99 | 18:00:59 |
| Bid Price | Ask Price | Spread | Spread % | News | |
|---|---|---|---|---|---|
| 2.89 | 5.75 | 2.86 | 49.74% | - | - |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 821 | 162,665 | $ 4.11 | $ 669,324 | 84,342 | 2.61 - 22.99 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 17:22:21 | formt | 515 | $ 4.15 | USD |
Aptinyx Financials
| Market Cap | Shares in Issue | Profit/Loss | Earnings Per Share (EPS) | PE Ratio | Float |
|---|---|---|---|---|---|
| $ 139.71M | 33.66M | $ -53.28M | -2.79 | - | 32.31M |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | 8.00 | 4.00% |
Aptinyx News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical APTX Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 3.91 | 4.22 | 3.637 | 3.93 | 74,064 | 0.24 | 6.14% |
| 1 Month | 3.11 | 4.22 | 3.07 | 3.49 | 90,091 | 1.04 | 33.44% |
| 3 Months | 4.05 | 4.22 | 2.61 | 3.39 | 98,788 | 0.10 | 2.47% |
| 6 Months | 3.15 | 4.89 | 2.61 | 3.43 | 144,691 | 1.00 | 31.75% |
| 1 Year | 20.41 | 22.99 | 2.61 | 5.23 | 241,878 | -16.26 | -79.67% |
| 3 Years | 17.40 | 32.25 | 2.61 | 9.18 | 211,184 | -13.25 | -76.15% |
| 5 Years | 17.40 | 32.25 | 2.61 | 9.18 | 211,184 | -13.25 | -76.15% |
Aptinyx Description
| Aptinyx Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel, proprietary, synthetic small molecules for the treatment of brain and nervous system disorders. Its pipeline products are NYX-2925, NYX-458, and NYX-783. NYX-2925 is a novel, oral, small-molecule NMDA receptor modulator in clinical development as a therapy for chronic pain. NYX-2925 works by enhancing synaptic plasticity, a mechanism uniquely suited to addressing chronic pain, and NYX-783 is an NMDA receptor modulating small molecule in clinical development as a therapy for post-traumatic stress disorder. |
